IMMA health News
8 articles
IMMA Health raises $2.5M to bring at-home ultrasound to IVF patients | CTech
IMMA Health, an Israeli medtech company, has secured a follow-on funding of $2.5 million as part of a $4.8 million Seed round led by iXcore, with additional support from the Israel Innovation Authority. The company is developing portable ultrasound devices for women undergoing fertility treatments, aiming to reduce the need for frequent clinic visits. Their platform uses an AI engine to perform 3D scans and transmit data to medical teams. The funding will support product development, clinical trials, and market entry in Europe and North America. The global fertility monitoring market is expected to grow significantly, presenting a substantial opportunity for IMMA Health.
InvestmentProduct Stage
מחקר שהתפרסם ב-Nature מציע כלי גנטי חדש לניבוי סיכון להשמנה עוד לפני גיל 5 ● אינספייר גייסה 40 מיליון דולר לאחר אישור ה-FDA ● מג'נטיק איי מגייסת לקולונוסקופיה מבוססת AI ● המל"ג ישקיע 10 מיליון שקל בפרויקט "רופא חוקר" ● וגם: גיוס לסטארט-אפ לתיקון מסתם הלב ושיתוף-פעולה אירופי ל-Imma Health הישראלית ● השבוע בביומד
InspireMD, a company developing a stent system to prevent strokes, has raised $40 million following FDA approval. The funds, led by OrbiMed and Marshall Wace, will be used for marketing in the U.S. The companys stock rose by 13% on NASDAQ, valuing it at $82 million. InspireMD had previously received a significant investment to conduct a major clinical trial in the U.S. The company is entering a competitive market with its carotid artery stents, which have insurance reimbursement approval from CMS. Meanwhile, Magentiq EYE, an Israeli company, raised an undisclosed amount in a Series A round to launch its AI-enhanced colonoscopy software.
InvestmentFDA approved/pending approval
The company has raised a total of $1.1 million to develop the first robotic, self-operated ultrasound system designed for women to use at home.
IMMA Health has raised $1.1 million to develop a robotic, self-operated ultrasound system for IVF patients, allowing them to conduct ultrasounds at home. This innovation aims to reduce the stress and inconvenience of frequent clinic visits, offering a more scalable and humane approach to fertility care. The system is currently in a pilot stage at Assuta IVF Centre in Israel, with plans for U.S. market entry in 2026. The company is leveraging AI technology to enhance remote care models and improve access to fertility treatment. The investment will support product development, clinical trials, and regulatory submissions.
Product StageInvestmentCustomersPartners
Béatrice Chemla, the Franco-Israeli Entrepreneur Reinventing Women's Health from Israel
LinkedIn Login, Sign in | LinkedIn IMMA
On April 3rd, IMMA had the honor of pitching at The Ventures Israel in Tel Aviv — alongside an inspiring group of startups driving innovation across AI, robotics, and digital health. We're incredibly proud to share that IMMA Health won Best Team!
The provided text is a generic message about signing into a LinkedIn account using a one-time link sent to the users primary email address. It advises checking the spam folder if the email is not found in the inbox. There is no information about any company, investment, acquisition, or other business-related events.
Why is the gender gap in tech so large? Entrepreneurs push for change at FemTech 2024
The summit celebrated the success of several groundbreaking startups, including IMMA Health, a company led by CEO and co-founder Beatrice Chemla.
The FemTech 2024 summit, hosted by Women in Tech Israel, brought together female entrepreneurs and industry leaders to address the gender gap in technology. The event emphasized mentorship, confidence, and persistence as strategies to overcome systemic inequalities. Discussions highlighted the challenges women face in tech, particularly in leadership roles, and celebrated the success of startups like IMMA Health, which offers a portable ultrasound solution for women. Despite the progress, female founders still face difficulties in raising funds, especially for womens health initiatives. The summit fostered a supportive environment for women to network, share experiences, and strategize on thriving in male-dominated industries.
MedFemTech: a glimpse into the future
IMMA is one of the winners of this year MassChallenge Israel competition. IMMA is a women-led new Israeli venture, created by Dr. Beatrice Chemla and Dr. Nadia Prisant, two graduates of our MBA in Healthcare Innovation, led by Prof. Varda Liberman
